233 related articles for article (PubMed ID: 28117725)
1. Envelope Protein Mutations L107F and E138K Are Important for Neurovirulence Attenuation for Japanese Encephalitis Virus SA14-14-2 Strain.
Yang J; Yang H; Li Z; Wang W; Lin H; Liu L; Ni Q; Liu X; Zeng X; Wu Y; Li Y
Viruses; 2017 Jan; 9(1):. PubMed ID: 28117725
[TBL] [Abstract][Full Text] [Related]
2. Acidity/Alkalinity of Japanese Encephalitis Virus E Protein Residue 138 Alters Neurovirulence in Mice.
Zheng X; Zheng H; Tong W; Li G; Wang T; Li L; Gao F; Shan T; Yu H; Zhou Y; Qiu Y; Ma Z; Tong G
J Virol; 2018 Nov; 92(22):. PubMed ID: 30158291
[TBL] [Abstract][Full Text] [Related]
3. Genetic Determinants of Japanese Encephalitis Virus Vaccine Strain SA14-14-2 That Govern Attenuation of Virulence in Mice.
Gromowski GD; Firestone CY; Whitehead SS
J Virol; 2015 Jun; 89(12):6328-37. PubMed ID: 25855730
[TBL] [Abstract][Full Text] [Related]
4. Molecular basis for attenuation of neurovirulence of a yellow fever Virus/Japanese encephalitis virus chimera vaccine (ChimeriVax-JE).
Arroyo J; Guirakhoo F; Fenner S; Zhang ZX; Monath TP; Chambers TJ
J Virol; 2001 Jan; 75(2):934-42. PubMed ID: 11134306
[TBL] [Abstract][Full Text] [Related]
5. A molecularly cloned, live-attenuated japanese encephalitis vaccine SA14-14-2 virus: a conserved single amino acid in the ij Hairpin of the Viral E glycoprotein determines neurovirulence in mice.
Yun SI; Song BH; Kim JK; Yun GN; Lee EY; Li L; Kuhn RJ; Rossmann MG; Morrey JD; Lee YM
PLoS Pathog; 2014 Jul; 10(7):e1004290. PubMed ID: 25077483
[TBL] [Abstract][Full Text] [Related]
6. The A66G back mutation in NS2A of JEV SA14-14-2 strain contributes to production of NS1' protein and the secreted NS1' can be used for diagnostic biomarker for virulent virus infection.
Wang J; Li X; Gu J; Fan Y; Zhao P; Cao R; Chen P
Infect Genet Evol; 2015 Dec; 36():116-125. PubMed ID: 26384477
[TBL] [Abstract][Full Text] [Related]
7. A novel amino acid site closely associated with the neurovirulence of live, attenuated Japanese encephalitis vaccine (SA14-14-2 strain).
Yang H; Fan F; Liu L; Liu J; Sun Y; Xie A; Shi X; Liu L; Yu Y; Li Y; Ge Y; Zeng X; Yang H
Vaccine; 2020 Mar; 38(11):2636-2642. PubMed ID: 32044162
[TBL] [Abstract][Full Text] [Related]
8. Comparison of the live-attenuated Japanese encephalitis vaccine SA14-14-2 strain with its pre-attenuated virulent parent SA14 strain: similarities and differences in vitro and in vivo.
Yun SI; Song BH; Polejaeva IA; Davies CJ; White KL; Lee YM
J Gen Virol; 2016 Oct; 97(10):2575-2591. PubMed ID: 27498826
[TBL] [Abstract][Full Text] [Related]
9. The pre membrane and envelope protein is the crucial virulence determinant of Japanese encephalitis virus.
Leng SL; Huang R; Feng YN; Peng LJ; Yang J; Li YH
Microb Pathog; 2020 Nov; 148():104492. PubMed ID: 32916243
[TBL] [Abstract][Full Text] [Related]
10. Molecular basis of attenuation of neurovirulence of wild-type Japanese encephalitis virus strain SA14.
Ni H; Chang GJ; Xie H; Trent DW; Barrett AD
J Gen Virol; 1995 Feb; 76 ( Pt 2)():409-13. PubMed ID: 7844560
[TBL] [Abstract][Full Text] [Related]
11. Characterization of the E-138 (Glu/Lys) mutation in Japanese encephalitis virus by using a stable, full-length, infectious cDNA clone.
Zhao Z; Date T; Li Y; Kato T; Miyamoto M; Yasui K; Wakita T
J Gen Virol; 2005 Aug; 86(Pt 8):2209-2220. PubMed ID: 16033968
[TBL] [Abstract][Full Text] [Related]
12. Chimeric yellow fever virus 17D-Japanese encephalitis virus vaccine: dose-response effectiveness and extended safety testing in rhesus monkeys.
Monath TP; Levenbook I; Soike K; Zhang ZX; Ratterree M; Draper K; Barrett AD; Nichols R; Weltzin R; Arroyo J; Guirakhoo F
J Virol; 2000 Feb; 74(4):1742-51. PubMed ID: 10644345
[TBL] [Abstract][Full Text] [Related]
13. Characterization of live-attenuated Japanese encephalitis vaccine virus SA14-14-2.
Yang D; Li XF; Ye Q; Wang HJ; Deng YQ; Zhu SY; Zhang Y; Li SH; Qin CF
Vaccine; 2014 May; 32(23):2675-81. PubMed ID: 24709585
[TBL] [Abstract][Full Text] [Related]
14. Phenotypic and genotypic characteristics of Japanese encephalitis attenuated live vaccine virus SA14-14-2 and their stabilities.
Yu Y
Vaccine; 2010 May; 28(21):3635-41. PubMed ID: 20226891
[TBL] [Abstract][Full Text] [Related]
15. Mechanism of virulence attenuation of glycosaminoglycan-binding variants of Japanese encephalitis virus and Murray Valley encephalitis virus.
Lee E; Lobigs M
J Virol; 2002 May; 76(10):4901-11. PubMed ID: 11967307
[TBL] [Abstract][Full Text] [Related]
16. Mutation of I176R in the E coding region weakens Japanese encephalitis virus neurovirulence, but not its growth rate in BHK-21 cells.
Zhou Y; Wu R; Zhao Q; Chang YF; Wen X; Feng Y; Huang X; Wen Y; Yan Q; Huang Y; Ma X; Han X; Cao S
Arch Virol; 2018 May; 163(5):1351-1355. PubMed ID: 29411136
[TBL] [Abstract][Full Text] [Related]
17. Phenotypic and Genotypic Comparison of a Live-Attenuated Genotype I Japanese Encephalitis Virus SD12-F120 Strain with Its Virulent Parental SD12 Strain.
Anwar MN; Wang X; Hameed M; Wahaab A; Li C; Sharma M; Pang L; Malik MI; Liu K; Li B; Qiu Y; Wei J; Ma Z
Viruses; 2020 May; 12(5):. PubMed ID: 32429445
[TBL] [Abstract][Full Text] [Related]
18. Envelope protein gene based molecular characterization of Japanese encephalitis virus clinical isolates from West Bengal, India: a comparative approach with respect to SA14-14-2 live attenuated vaccine strain.
Sarkar A; Banik A; Pathak BK; Mukhopadhyay SK; Chatterjee S
BMC Infect Dis; 2013 Aug; 13():368. PubMed ID: 23927571
[TBL] [Abstract][Full Text] [Related]
19. Molecular phylogenetic and positive selection analysis of Japanese encephalitis virus strains isolated from pigs in China.
Liu WJ; Zhu M; Pei JJ; Dong XY; Liu W; Zhao MQ; Wang JY; Gou HC; Luo YW; Chen JD
Virus Res; 2013 Dec; 178(2):547-52. PubMed ID: 24045128
[TBL] [Abstract][Full Text] [Related]
20. The mutation of Japanese encephalitis virus envelope protein residue 389 attenuates viral neuroinvasiveness.
Huang R; He Y; Zhang C; Luo Y; Chen C; Tan N; Ren Y; Xu K; Yuan L; Yang J
Virol J; 2024 Jun; 21(1):128. PubMed ID: 38840203
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
